Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Xetra  >  Lanxess AG    LXS   DE0005470405

LANXESS AG

(LXS)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

LANXESS : aims to acquire disinfection and hygiene solutions provider Theseo

01/11/2021 | 05:22am EST
Specialty chemicals company LANXESS intends to further expand its Consumer Protection business and has entered into exclusive negotiations to acquire the Theseo group. The French group, headquartered in Laval, is a leading manufacturer of disinfection and hygiene solutions in Europe and Latin America. The products are used in particular in livestock farming to prevent and control diseases. Subject to completion of the transaction, LANXESS will significantly expand its range of products for the growth market animal hygiene and will in future also be able to offer products for the animal nutrition industry.

Prior to the execution of the envisaged transaction, the usual French employee information and consultation process will be followed. Furthermore, the transaction is subject to antitrust clearance. Thereupon, the parties expect the envisaged transaction to be completed in mid-2021.

'We are focusing on profitable specialty chemicals and here consumer protection products play an important role. Once we complete the planned acquisition of Theseo, we will yet again expand our high-margin business in this area,' said Matthias Zachert, Chairman of the Board of Management of LANXESS AG.

LANXESS plans to finance the envisaged acquisition with an enterprise value of approximately EUR 70 million out of cash. In 2020, Theseo is expected to generate sales of around EUR 33 million and an EBITDA in the mid-single-digit million euro range. Within three years following the completion of the planned transaction, LANXESS expects an additional annual EBITDA contribution in the same amount from synergy effects. The envisaged acquisition will already be earnings per share (EPS) accretive in the first fiscal year after its completion.

Perfect addition to the material protection business

Theseo has about 100 employees and sites in Laval (France), Wietmarschen (Germany), Hull (UK) and Campinas (Brazil). LANXESS intends to integrate the business into its Material Protection Products business unit, where it would complement the portfolio of disinfection and hygiene solutions.

Theseo offers an extensive portfolio of disinfection and hygiene products for all areas of pig and poultry. Herein, LANXESS sees strong growth prospects due to rising biosecurity requirements. Theseo also has a well-positioned portfolio in water hygiene as well as animal nutrition. With the continuous drive towards antibiotic free meat, these products play an ever-growing role in livestock production.

LANXESS' materials protection business

The LANXESS Material Protection Products business unit employs around 660 employees and has production sites in Krefeld-Uerdingen and Dormagen (Germany), Sudbury (Great Britain), Pittsburgh and Memphis (USA), Jarinu (Brazil), Jhagadia (India), Changzhou (China) and Singapore.

Disclaimer

Lanxess AG published this content on 11 January 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 11 January 2021 10:21:02 UTC


© Publicnow 2021
All news about LANXESS AG
02/26LANXESS AG : Buy rating from Berenberg
MD
02/23LANXESS : Smooth and nimble cutting through sheet metal
PU
02/18Dow Inc seeks buyers for German chemical parks infrastructure -sources
RE
02/16LANXESS AG : Independant Research sticks Neutral
MD
02/16LANXESS AG : Warburg Research reiterates its Buy rating
MD
02/16LANXESS : Moody's Confirms Lanxess at Baa2, Keeps Outlook Stable
MT
02/15LANXESS AG : Gets a Buy rating from Baader Bank
MD
02/15LANXESS AG : Receives a Buy rating from DZ Bank
MD
02/15LANXESS AG : Baader Bank gives a Buy rating
MD
02/15LANXESS AG : Warburg Research maintains a Buy rating
MD
More news
Financials
Sales 2020 6 094 M 7 356 M 7 356 M
Net income 2020 891 M 1 075 M 1 075 M
Net Debt 2020 1 407 M 1 699 M 1 699 M
P/E ratio 2020 5,87x
Yield 2020 1,52%
Capitalization 5 295 M 6 406 M 6 391 M
EV / Sales 2020 1,10x
EV / Sales 2021 1,09x
Nbr of Employees 14 351
Free-Float 90,3%
Chart LANXESS AG
Duration : Period :
Lanxess AG Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends LANXESS AG
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 21
Average target price 67,80 €
Last Close Price 61,32 €
Spread / Highest target 38,6%
Spread / Average Target 10,6%
Spread / Lowest Target -20,1%
EPS Revisions
Managers and Directors
NameTitle
Matthias Zachert Chairman-Management Board
Michael Pontzen Chief Financial Officer
Matthias L. Wolfgruber Chairman-Supervisory Board
Werner Czaplik Member-Supervisory Board
Theo H. Walthie Member-Supervisory Board
Sector and Competitors
1st jan.Capitalization (M$)
LANXESS AG-2.29%6 406
BASF SE4.65%75 267
SHIN-ETSU CHEMICAL CO., LTD.-3.82%67 583
DUPONT DE NEMOURS, INC.-1.11%37 838
ROYAL DSM N.V.-3.02%28 016
EVONIK INDUSTRIES AG4.54%15 697